Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

51.84
Delayed Data
As of Nov 22
 +0.09 / +0.17%
Today’s Change
30.89
Today|||52-Week Range
51.99
+44.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line1.2B1.5B1.5B1.6B
 
 
 
 
 
Depreciation143.8M102.0M129.2M112.9M
 
 
 
 
 
Total Other Cash Flow231.7M192.7M136.1M403.4M
 
 
 
 
 
Funds From Operations1.6B1.8B1.8B2.1B
 
 
 
 
 
Funds From/For Other Operating Expenses23.1M13.0M234.7M29.8M
 
 
 
 
 
Net Cash Flow - Operating Activities1.6B1.7B1.5B2.0B
 
 
 
 
 
 
InvestingIncrease In Investments15.6M0.00-5.9M5.9M
 
 
 
 
Decrease In Investments-127.7K144.9M152.0M6.3M
 
 
 
 
 
Capital Expenditures-365.1M-231.0M-233.9M-306.2M
 
 
 
 
 
Fixed Asset Disposal738.5K----23.8K
 
 
 
Other Investing - Uses-16.6M0.000.00-6.0M
 
 
 
Other Investing - Sources3.4M0.000.001.7M
 
 
 
Net Cash Flow Investing-399.0M-101.7M-108.9M-308.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-591.4M-611.4M-566.8M-672.4M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total34.3M-1.6B-36.1M-1.2B
 
 
 
 
 
Other Sources - Financing0.00283.5M-283.5M0.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-557.1M-2.0B-886.3M-1.8B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.0M1.2M-25.0M-10.8M
 
 
 
 
 
 
Net Change In Cash644.0M-334.0M532.0M-101.1M